Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts → Biden replacement revealed? (From Paradigm Press) (Ad) Free LLY Stock Alerts $775.00 -2.77 (-0.36%) (As of 05/8/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 6) $2.58 Beat By $0.05 Consensus EPS (May. 6) $2.53 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Eli Lilly and Company Earnings AlertsEnter your email address below to receive the latest news and earnings results for LLY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLLY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LLY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Eli Lilly and Company Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$2.34$2.74$2.54 Q2 20243$2.41$2.89$2.63 Q3 20243$2.93$3.75$3.32 Q4 20243$3.04$4.82$3.89 FY 202412$10.72$14.20$12.39 Q1 20251$4.77$4.77$4.77 Q2 20251$4.07$4.07$4.07 Q3 20251$4.46$4.46$4.46 Q4 20251$4.50$4.50$4.50 FY 20254$17.80$17.80$17.80 Q1 20261$6.06$6.06$6.06 LLY Earnings Date and InformationEli Lilly and Company last issued its quarterly earnings results on May 6th, 2024. The reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.05. The business earned $8.77 billion during the quarter, compared to analyst estimates of $8.94 billion. Its quarterly revenue was up 26.0% compared to the same quarter last year. Eli Lilly and Company has generated $6.79 earnings per share over the last year ($6.79 diluted earnings per share) and currently has a price-to-earnings ratio of 114.1. Earnings for Eli Lilly and Company are expected to grow by 36.47% in the coming year, from $13.82 to $18.86 per share. Eli Lilly and Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Eli Lilly and Company Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 5/6/2024Q1 2024$2.53$2.58+$0.05$2.68$8.94 billion$8.77 billion 2/6/2024Q4 2023$2.30$2.49+$0.19$2.56$8.95 billion$9.35 billion 11/2/2023Q3 2023($0.08)$0.10+$0.18$0.26$8.88 billion$9.50 billion8/8/2023Q2 2023$1.98$2.11+$0.13$2.27$7.58 billion$8.31 billion 4/27/2023Q1 2023$1.73$1.62($0.11)$1.75$6.87 billion$6.96 billion 2/2/2023Q4 2022$1.83$2.09+$0.26$2.04$7.39 billion$7.30 billion Get the Latest News and Ratings for LLY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter. 11/1/2022Q3 2022$1.97$1.98+$0.01$2.35$6.91 billion$6.94 billion8/4/2022Q2 2022$1.80$1.25($0.55)$1.45$6.85 billion$6.49 billion 4/28/2022Q1 2022$2.32$2.62+$0.30$3.14$7.29 billion$7.81 billion 2/3/2022Q4 2021$2.51$2.49($0.02)$3.08$7.89 billion$8.00 billion 10/25/2021Q3 2021$1.98$1.94($0.04)$2.66$6.64 billion$6.77 billion 8/2/2021Q2 2021$1.89$1.87($0.02)$2.21$6.59 billion$6.74 billion Eli Lilly and Company Earnings - Frequently Asked Questions When is Eli Lilly and Company's earnings date? Eli Lilly and Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on LLY's earnings history. Did Eli Lilly and Company beat their earnings estimates last quarter? In the previous quarter, Eli Lilly and Company (NYSE:LLY) reported $2.58 earnings per share (EPS) to beat the analysts' consensus estimate of $2.53 by $0.05. Learn more on analysts' earnings estimate vs. LLY's actual earnings. How can I listen to Eli Lilly and Company's earnings conference call? The conference call for Eli Lilly and Company's latest earnings report can be listened to online. Listen to Conference Call How can I read Eli Lilly and Company's conference call transcript? The conference call transcript for Eli Lilly and Company's latest earnings report can be read online. Read Transcript How can I view Eli Lilly and Company's earnings report? Eli Lilly and Company's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $35.93 billion. How much profit does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded net income of $5.24 billion. LLY has generated $6.79 earnings per share over the last four quarters. What is Eli Lilly and Company's price-to-earnings ratio? Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 114.14 and a forward price-to-earnings ratio of 56.08. The price/earnings-to-growth ratio is 1.45. What is Eli Lilly and Company's EPS forecast for next year? Eli Lilly and Company's earnings are expected to grow from $13.82 per share to $18.86 per share in the next year, which is a 36.47% increase. More Earnings Resources from MarketBeat Related Companies: Johnson & Johnson Earnings Results Merck & Co., Inc. Earnings Results AbbVie Earnings Results Novo Nordisk A/S Earnings Results AstraZeneca Earnings Results Novartis Earnings Results UnitedHealth Group Earnings Results Thermo Fisher Scientific Earnings Results Pfizer Earnings Results Bristol-Myers Squibb Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NYSE:LLY) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
